GE, Cardinal Accused Of Manipulating Cardiac Imaging Market

Law360, New York (March 27, 2012, 10:25 PM EDT) -- A California nuclear pharmacy on Monday filed a putative class action against GE Healthcare Inc. and Cardinal Health Inc., alleging the companies conspired to keep prices for their cardiac imaging agents high by refusing to sell them to independent pharmacies.

In a complaint filed in California federal court, PharmaRx Pharmaceutical Inc. claims GE refused to sell Myoview and other GE proprietary products to independent nuclear pharmacies, or radiopharmacies, in areas where there was already a GE-operated radiopharmacy.

And after a 2008 agreement made to allegedly keep...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

PharmaRx Pharmaceutical Inc v. GE Healthcare Inc et al


Case Number

2:12-cv-02594

Court

California Central

Nature of Suit

Anti-Trust

Judge

Mariana R. Pfaelzer

Date Filed

March 26, 2012

Law Firms

Companies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.